Shivani K. Thaker, Adam Dugan, Unnati Jariwala, Binyam Yilma, Michelle Weitz, Stamatina Fragkogianni, Samer Alkassis, Marla Lipsyc-Sharf, Alexis Ann LeVee, Yuan Yuan, Funda Meric-Bernstam, Hope S. Rugo, Joyce O'Shaughnessy, Mothaffar Rimawi, Rachel Schiff, David Elashoff, Martina Mcdermott, Amy Lauren Cummings, Jacob Mercer, Aditya Bardia. "Association between HER family expression and clinical outcomes with trastuzumab deruxtecan (T-DXd) in patients with hormone receptor–positive/HER2-negative (HR+/HER2-) metastatic breast cancer (mBC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1030